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ABSTRACT 
Ligand-dependent differences in the regulation 
and internalization of the mu-opioid receptor 
(MOR) have been linked to the severity of 
adverse effects that limit opiate use in pain 
management. MOR activation by morphine or 
[D-Ala2,N-MePhe4,Gly-ol]-enkephalin 
(DAMGO) causes differences in 
spatiotemporal signaling dependent on MOR 
distribution at the plasma membrane. Morphine 
stimulation of MOR activates a Gai/o–Gbg–
protein kinase C (PKC)a phosphorylation 
pathway that limits MOR distribution and is 
associated with a sustained increase in 
cytosolic extracellular signal–regulated kinase 
(ERK) activity. In contrast, DAMGO causes a 
redistribution of the MOR at the plasma 
membrane (before receptor internalization), 
that facilitates transient activation of cytosolic 
and nuclear ERK. Here, we used proximity 
biotinylation proteomics to dissect the different 
protein-interaction networks that underlie the 
spatiotemporal signaling of morphine and 
DAMGO. We found that DAMGO, but not 
morphine, activates Ras-related C3 botulinum 
toxin substrate 1 (Rac1). Both Rac1 and 
nuclear ERK activity was dependent on the 
scaffolding proteins IQ motif–containing 
GTPase-activating protein-1 (IQGAP1) and 
Crk-like protein (CRKL). In contrast, 
morphine increased the proximity of the MOR 
to desmosomal proteins, which form 
specialized and highly ordered membrane 
domains. Knockdown of two desmosomal 
proteins, junction plakoglobin (JUP) or 
desmocolin-1 (DSC1), switched the morphine 
spatiotemporal signaling profile to mimic that 
of DAMGO, resulting in a transient increase in 
nuclear ERK activity. The identification of the 
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MOR-interaction networks that control 
differential spatiotemporal signaling reported 
here is an important step towards 
understanding how signal 
compartmentalization contributes to opioid-
induced responses including anti-nociception 
and the development of tolerance and 
dependence. 
 
 
The mu-opioid receptor (MOR) is a G protein-
coupled receptor (GPCR) that mediates the 
effects of opioid-based analgesics such as 
morphine (1). Analgesics targeting the MOR 
remain the most effective drugs for the 
treatment of severe pain. This is despite 
limitations associated with chronic use of 
opioid analgesics including the development of 
dependence, addiction and respiratory 
depression (2), contributing factors to opioid-
induced overdose deaths that have increased in 
the last decade (3). 
 
The MOR is differentially regulated by 
morphine compared to other high efficacy 
opioid ligands, such as the enkephalin 
analogue, DAMGO ([D-Ala2,N-MePhe4,Gly-
ol]-enkephalin). In particular, morphine causes 
limited receptor phosphorylation and 
recruitment of the scaffolding protein b-
arrestin, which results in compromised receptor 
internalization and resensitization (4-7). The 
distinct ligand-dependent regulatory profiles of 
MOR also correlate with differences in 
spatiotemporal signaling. Previously, we have 
shown that DAMGO causes a redistribution of 
the MOR at the plasma membrane, and this is 
associated with a transient increase in both 
cytosolic and nuclear extracellular signal 
regulated kinase (ERK) that occurs prior to 
receptor internalization (8). In contrast, 
morphine is unable to cause any change in 
MOR distribution at the plasma membrane. 
This is due to activation of a Gai/o-Gbg-protein 
kinase C (PKC)a phosphorylation pathway, 
and results in a sustained increase in cytosolic 
ERK only. Release of the morphine-stimulated 
MOR from this limited microdomain (by 
inhibition of Gbg, PKC, or disruption of the 
lipid organization of the plasma membrane) 
caused redistribution of the receptor and 
activation of nuclear ERK (8). Therefore, 
different ligands cause clear differences in the 
spatial organization of the receptor which 
controls its spatiotemporal signaling. The 
molecular mechanism through which this 
change in receptor distribution leads to distinct 
signaling patterns remains to be addressed. 
 
The activation of different spatiotemporal 
signaling pathways by a GPCR can be 
controlled by a change in receptor location (8, 
9), but may also be dependent on the 
organization of different effector/regulatory 
proteins in close proximity to the receptor (10, 
11). Such a protein-interaction network could 
be physically associated with the GPCR or 
occur in close proximity within a localized area 
of the plasma membrane. Until recently, 
identification of a GPCR-signaling complex 
required a prior knowledge of candidate 
proteins (e.g. functionally, by targeting likely 
candidates with chemical inhibitors or gene 
silencing, or physically, by choosing targets to 
identify during immunoblotting or 
immunostaining). Confirmation of a physical 
interaction within a complex could then be 
confirmed by biochemical or imaging 
techniques (e.g. co-immunoprecipitation, 
Förster resonance energy transfer [FRET] or 
proximity ligation assay). This approach has its 
limitations, as the investigator must first 
choose a likely candidate, and biochemical 
isolation of protein complexes usually 
preserves only very strong/direct interactions. 
The rise of proximity biotinylation proteomics 
approaches (12, 13) has provided an unbiased 
method to identify candidate proteins that may 
form protein-interaction networks with a 
GPCR, and has the distinct advantage over 
affinity-purification-based approaches of 
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detecting transient, weak and more distal 
interactions. 
 
Here, we have used APEX2 (ascorbate 
peroxidase from the soy bean) proximity 
biotinylation proteomics to show that 
activation of MOR by DAMGO or morphine 
induces the assembly of different protein-
interaction networks, and that these protein-
interaction networks are critical for the 
activation of downstream signaling. DAMGO 
stimulation of the MOR led to increased 
proximity of the receptor to proteins that are 
essential for receptor internalization, but also 
identified protein-networks involved in the 
activation of small G proteins. Based on this we 
found a DAMGO-mediated activation of Rac1, 
a small G protein of the Rho family of GTPases 
which are important regulators of cytoskeletal 
organization and trafficking (14). The 
activation of Rac1 by MOR was dependent on 
two scaffolding proteins, IQ motif-containing 
GTPase-activating protein-1 (IQGAP1) and 
Crk-like protein (CRKL). Moreover, both 
IQGAP1 and CRKL were required for the 
DAMGO-mediated activation of nuclear ERK. 
In contrast, morphine stimulation of the MOR 
led to an increased proximity of the receptor to 
protein-networks that are critical for the 
formation of desmosomes. Desmosomes are 
specialized regions of the plasma membrane 
that form cell-cell junction complexes and can 
assemble signaling hubs (15, 16). Knockdown 
of desmosomal proteins desmocolin-1 (DSC1) 
and junction plakoglobin (JUP) transformed 
the morphine spatiotemporal signaling profile 
into that of DAMGO: transient activation of 
nuclear ERK. This suggests that the restricted 
distribution of MOR in response to morphine 
(and therefore activation of sustained ERK 
within the cytoplasm) is, at least in part, 
dependent on the formation of desmosome 
protein-networks around the receptor. These 
data show that the distinct spatiotemporal 
signaling profiles stimulated by DAMGO 
compared to morphine activation of the MOR 
are not only dependent on the spatial 
organization of the receptor at the plasma 
membrane, but also on the assembly of distinct 
protein-interaction networks in close proximity 
to the receptor. 
 
RESULTS 
MOR-APEX2 maintains the spatiotemporal 
ERK signaling of the wild-type MOR 
To identify protein-interaction networks that 
are important for activation of the distinct 
spatiotemporal signaling profiles elicited by 
DAMGO vs morphine stimulation of the MOR, 
we employed APEX2 (17) proximity 
biotinylation proteomics (Figure 1A). The 
APEX2 tag was added to the C-terminal tail of 
the FLAG-MOR (herein referred to as MOR), 
to generate FLAG-MOR-APEX2 (herein 
referred to as MOR-APEX2). As previously 
demonstrated for the MOR transiently 
expressed in HEK293 cells (8), all MOR-
APEX2 was expressed at the cell surface 
(Figure 1B, S1A), inhibited forskolin-
stimulated cAMP (Figure 1C) and recruited b-
arrestin 2 to the plasma membrane in response 
to DAMGO (Figure 1D). The lower level of 
expression of MOR-APEX (~31% compared to 
MOR) was reflected in the smaller degree of 
cAMP inhibition and b-arrestin 2 recruitment 
to the cell surface in response to DAMGO. 
Importantly, MOR-APEX2 also maintained the 
ligand-dependent spatiotemporal signaling 
profiles of MOR. Activation of both MOR and 
MOR-APEX2 with an EC80 concentration of 
DAMGO (10 nM) (8) caused a transient 
increase in cytosolic and nuclear ERK (Figure 
1E-H, S2). In contrast, an EC80 concentration 
of morphine (100 nM) (8) caused a sustained 
increase in cytosolic ERK, but no change in 
nuclear ERK activity compared to a vehicle 
control (Figure 1E-H, S2). Therefore, MOR-
APEX2 is functional and maintains the ligand-
dependent spatiotemporal signaling profile of 
MOR. 
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Activation of MOR-APEX2 by DAMGO causes 
biotinylation of G protein receptor kinase 
(GRK)2. 
Following the addition of biotin-tyramide to 
the cell culture medium, and activation by 
hydrogen peroxide, APEX2 biotinylates 
competent proximal proteins with its activity 
decreasing with distance over a 20 nm radius 
(18, 19). The biotinylated proteins can be 
identified by cell lysis and streptavidin 
pulldown, followed by either immunoblotting 
or mass spectrometry. To confirm functionality 
of the APEX2 tag within MOR-APEX2, we 
stimulated HEK293 cells transiently 
expressing MOR-APEX2 and a well-
characterized regulatory protein GRK2 (7), 
with 1 µM DAMGO (Figure 1I) or 1 µM 
morphine (Figure S1B) over a time course of 5 
min. GRK2 and GRK3 are important for 
receptor phosphorylation following activation 
by DAMGO, but not morphine (5, 7). As 
anticipated, the addition of DAMGO caused an 
increase in the biotinylation of GRK2 that 
peaked at 3-4 min, before declining at 5 min 
(Figure 1I, S1C). In contrast, there was no 
change in the amount of biotinylated GRK2 in 
response to morphine (Figure S1B-C). 
Interestingly, the kinetics of GRK2 
biotinylation occur over a longer timescale than 
our previous measurements of GRK2 
recruitment using bioluminescence resonance 
energy transfer (BRET) and FRET (plateau at 
2 min) (7). This suggests a lag period between 
the recruitment of the protein detected by 
BRET/FRET, and the ability to observe a 
detectable change in the biotinylation status of 
the same protein by immunoblotting. 
 
Proximity biotinylation after activation of 
MOR-APEX2 
As MOR-APEX2 activates the same 
spatiotemporal signaling pathways as MOR, 
and we can detect time-dependent changes in 
the biotinylation of proteins important in 
receptor regulation, we performed APEX2 
proximity biotinylation assays followed by 
tandem mass spectrometry (LC-MS-MS) to 
identify other proteins likely to contribute to 
ligand-dependent signaling. Cells transiently 
expressing MOR-APEX2 were treated with 
vehicle, 1 µM DAMGO or 1 µM morphine for 
10 min (after receptor redistribution but prior to 
internalization) or 60 min (after receptor 
internalization) (8). We used saturating 
concentrations of DAMGO and morphine to 
ensure full receptor occupancy and therefore 
maximal receptor activation and biotinylation 
of proximal proteins. Importantly, differential 
spatiotemporal signaling of the MOR is 
maintained in response to 1 µM DAMGO and 
1 µM morphine (Figure 4D). APEX2 was 
activated by 1 min treatment with hydrogen 
peroxide at the end of the stimulation period, 
before quenching, cell lysis and isolation of 
biotinylated proteins by streptavidin pulldown. 
Biotinylated proteins from three biological 
replicates were identified and quantified by 
LC-MS/MS. In total, 374 proteins were 
identified across three independent replicates 
of the six experimental conditions, with 219 
proteins showing a change in enrichment of 
more than 1.5-fold compared to vehicle 
controls (Figure 2A). While some proteins 
were enriched across all treatment groups, we 
also identified proteins that were unique to both 
drug treatment and time of stimulation.  In 
some cases, proteins were absent in vehicle-
treated samples but present following 
stimulation with DAMGO or morphine, or vice 
versa (i.e. ligand-induced). If this occurred in 
all three independent replicates, we imputed a 
fixed value for the missing conditions in order 
to analyze the data (see Methods). 
 
To validate the collected data-set we initially 
looked for protein-interaction networks 
relating to receptor endocytosis. This was 
chosen as it is well documented that DAMGO 
causes robust internalization of the MOR by 60 
min, whereas morphine causes very limited 
receptor internalization (8). Ingenuity Pathway 
Analysis (IPA) software identified a network of 
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proteins important for endocytosis that were 
differentially affected by DAMGO vs 
morphine stimulation of MOR-APEX2 (Figure 
2B-C, Table 1). For example, stimulation of 
MOR-APEX2 for 60 min with DAMGO, but 
not morphine, caused an enrichment in proteins 
essential for endocytosis, including clathrin 
heavy chain (CLTC) and Rab7a. 
 
Interestingly, while stimulation of MOR-
APEX2 for 10 min identified some proteins 
that were differentially affected by DAMGO vs 
morphine, IPA software did not identify any 
protein-interaction networks that were 
differentially affected by the two ligands at this 
time-point (Figure S3). In contrast, differences 
in protein-interaction networks were more 
apparent following 60 min stimulation with 
ligand, so these interaction networks were 
examined in more detail. 
 
DAMGO activates Rac1 signaling, dependent 
on IQGAP1 and CRKL 
We first looked for novel protein-interaction 
networks that were specific for DAMGO 
stimulation of MOR-APEX2. Three 
interconnected canonical pathways were 
identified that were exclusively affected by 
DAMGO: (i) actin cytoskeleton signaling, (ii) 
signaling by Rho family GTPases, and (iii) 
integrin signaling. We listed all proteins within 
these three canonical pathways that were 
identified in at least two out of the three 
biological replicates in response to DAMGO. 
Of this list, if a protein was found in only one 
biological replicate for vehicle or morphine 
treatment, it was excluded due to low 
confidence. The only exception to this was 
when a protein was completely absent in 
vehicle-treated samples but present in two out 
of the three biological replicates following a 
drug treatment, or vice versa (i.e. ligand-
dependent protein interactions). In this 
particular case and in order to visualize and 
analyze these data, missing values needed to be 
imputed. This stringent analysis criteria left a 
list of 15 proteins (Figure 3A and Table 2), of 
which the abundance of 10 were differentially 
affected by DAMGO vs morphine treatment 
(Figure 3B-C). 
 
IPA software highlighted signaling by Rho 
family GTPases (RhoA, Rac1 and Cdc42), and 
only DAMGO caused a large increase in the 
abundance of IQGAP1 (Figure 3C), which 
binds activated Cdc42 and Rac1 (but not 
RhoA) (20). We therefore looked for activation 
of Rac1 and Cdc42 in single live cells using 
FRET biosensors previously described (21, 
22). We observed no effect of DAMGO or 
morphine on the activity of Cdc42 in HEK293 
cells transiently expressing MOR and Raichu-
Cdc42 FRET biosensor (Figure S4). In 
contrast, DAMGO, but not morphine, 
stimulated a small but significant increase in 
Rac1 activity following MOR stimulation, as 
detected by the RaichuEV-Rac1 FRET 
biosensor (Figure 3D-E). We then determined 
whether IQGAP1 was important for the 
increase in Rac1 activity in response to 
DAMGO. There was no effect of a scrambled 
siRNA control on the Rac1 signal (Figure 3E-
F), however knockdown of IQGAP1 using 
targeted siRNA (mean±SD: 54.07±19.50% 
knockdown relative to control) abolished the 
Rac1 signal in response to DAMGO (Figure 
3E,G,H). In addition to IQGAP1, another 
protein with known scaffolding functions, 
CRKL, was uniquely enriched by DAMGO 
stimulation of MOR-APEX2 (Figure 3C). 
CRKL was of particular interest as it has 
SH2/SH3 protein-interaction domains and is 
implicated in the activation of ERK signaling 
(23, 24). As observed for IQGAP1, knockdown 
of CRKL using targeted siRNA (mean±SD: 
41.38±11.16% knockdown relative to control) 
abolished the DAMGO-stimulated increase in 
Rac1 activity (Figure 3E,I,J). There was no 
effect of knockdown of either IQGAP1 or 
CRKL on endogenous levels of Rac1 (Figure 
S5). Moreover, knockdown of both IQGAP1 
and CRKL also abolished the DAMGO-
MOR-interaction networks control spatiotemporal signaling 
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stimulated increase in nuclear ERK activity 
(Figure 3K, S6), as measured using the 
nucEKAR FRET biosensor (25). There was no 
effect of knockdown of IQGAP1 or CRKL on 
the maximal FRET change for either FRET 
biosensor (Figure S7). It is interesting to note 
that while the potential role of IQGAP1 and 
CRKL was identified due to increased 
biotinylation after 60 min of MOR stimulation, 
knockdown of the two proteins abolished ERK 
signaling at a much earlier time point (5 min). 
This “time discrepancy” is likely due to the 
different levels of amplification and detection 
thresholds for each assay. So while 
biotinylation of proteins proximal to the MOR 
(unamplified) requires longer to reach the 
detection threshold of the assay, activation of 
downstream signaling (highly amplified) can 
be detected much earlier. 
 
Therefore, activation of MOR by DAMGO, but 
not morphine, causes an increase in Rac1 
activity that is dependent on the scaffolding 
proteins IQGAP1 and CRKL, and both 
IQGAP1 and CRKL are required for DAMGO-
mediated activation of nuclear ERK. 
 
The spatiotemporal ERK signaling profile of 
morphine is controlled by desmosomal 
proteins. 
We then looked for protein-interaction 
networks that were specific for morphine 
activation of MOR-APEX2. We identified a 
network of interrelated proteins that were 
uniquely affected by morphine. This list was 
filtered based on the same criteria used for the 
DAMGO-specific proteins (i.e. proteins have 
to be identified in at least two out of three 
biological replicates), to leave 24 proteins 
(Figure 4A and Table 3), of which the 
abundance of 9 were differentially affected by 
morphine vs DAMGO treatment (Figure 4B-
C). 
 
Of these proteins, we identified an interaction-
network between Rab7a, JUP, DSC1, DSG1 
and caspase-14 (CASP14). JUP, DSC1 and 
DSG1 proteins are integral for the formation of 
desmosomes (15), and both CASP14 and 
Rab7a have been linked to these structures 
(26). Desmosomes are specialized and highly-
ordered membrane domains that mediate cell-
cell contact and strong adhesion (15). We have 
previously shown that the integrity of the 
plasma membrane is critical for the control of 
MOR spatiotemporal signaling, and that 
morphine stimulation of MOR restricts the 
plasma membrane distribution of the receptor 
via a Gai/o-Gbg-PKCa pathway (8). Inhibition 
of the Gbg-PKCa pathway, or disruption of the 
architecture of the plasma membrane using 
lipid-disruptors, allowed morphine to 
redistribute the MOR and activate transient 
ERK signals in the cytosol and nucleus (8). 
Given that PKCa is necessary for desmosome 
formation (27, 28) we assessed whether the 
close proximity of the MOR to desmosome 
protein-networks controlled the morphine-
stimulated ERK spatiotemporal signaling 
profile. 
 
DSC1 and DSG1 are expressed at low levels in 
HEK293 cells and we were unable to detect 
expression at the protein level by 
immunoblotting (Figure S8A,B). While we 
could detect DSC1 expression at the RNA level 
using quantitative qPCR (Figure 4G), we were 
unable to do so for DSG1. This suggests that 
DSG1 expression must be enriched in the 
vicinity of MOR in HEK293 cells such that we 
could detect biotinylated DSG1 using LC-
MS/MS but not DSG1 at the protein/RNA level 
from whole cells. We therefore focused on the 
desmosomal proteins DSC1 and JUP. The 
proteins were knocked-down using targeted 
siRNA and we measured nuclear ERK activity 
using the nucEKAR FRET biosensor in 
HEK293 cells expressing MOR (Figure 4D-J). 
Knockdown of DSC1 (mean±SD: 
63.13±13.73% knockdown relative to control) 
and JUP (mean±SD: 64.32±10.57% 
knockdown relative to control) by targeted 
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siRNA was confirmed using quantitative RT-
PCR (Figure 4G) or immunoblotting (Figure 
4I), respectively. There was no effect of a 
scrambled siRNA control (Figure 4E,J), 
however knockdown of DSC1 (Figure 4F,G,J) 
or JUP (Figure 4H-J) allowed morphine to 
stimulate a transient increase in nuclear ERK. 
There was no effect of knockdown of these 
proteins on the ability of DAMGO to increase 
nuclear ERK (Figure 4D-J). 
 
Therefore, morphine, but not DAMGO, 
activation of MOR leads to an increased 
proximity of the receptor to demosome protein-
networks. Knockdown of demosomal proteins 
DSC1 or JUP facilitates a transient increase in 
nuclear ERK in response to morphine. 
 
DISCUSSION 
The MOR is an important therapeutic target in 
the treatment of pain, however, the efficacy of 
current drugs is limited by their side effects (2). 
Different ligands that activate the MOR are 
able to cause distinct patterns of receptor 
phosphorylation, leading to differential 
receptor regulation and internalization (7). 
New drugs are currently being developed that 
exploit these key differences in receptor 
regulation following activation (29). 
Previously, we reported that different ligands 
also stimulate distinct spatiotemporal patterns 
of signaling (8). This occurred prior to MOR 
internalization, and instead was dependent on 
the organization of the MOR at the plasma 
membrane. Here, using non-biased proximity 
biotinylation mass spectrometry we have 
identified novel proteins that are in close 
proximity to the MOR following stimulation 
with DAMGO vs morphine. While it is 
possible that the fusion of MOR with APEX2 
may alter the proteins that can interact with the 
receptor, we were able to confirm that the 
identified protein-networks are important for 
the wild-type MOR by using target knockdown 
or by directly measuring activation of 
signalling pathways. We find that DAMGO 
stimulation of MOR causes an activation of 
Rac1, dependent on IQGAP1 and CRKL 
scaffolding proteins (Figure 5). Both 
scaffolding proteins are also required for 
DAMGO-mediated increases in nuclear ERK 
activity. In contrast, morphine increases the 
proximity between the MOR and desmosomal 
proteins (including DSC1 and JUP) (Figure 5). 
Knockdown of DSC1 and JUP appears to 
release MOR from its restricted microdomain 
and allow transient increases in nuclear ERK in 
response to morphine. 
 
The use of unbiased proximity biotinylation 
proteomics has allowed us to identify a novel 
signaling pathway for MOR; only DAMGO, 
but not morphine, causes the activation of the 
small Rho GTPase Rac1. Rho GTPases such as 
Rac1 modulate the actin cytoskeleton in many 
cells including neurons (30), where the actin 
cytoskeleton is critical for the morphology of 
dendritic spines (31, 32). More than 90% of 
excitatory synaptic transmission occurs at 
dendritic spines (32), and they are critical for 
normal cognitive function and development 
(32). Interestingly, the function and 
morphology of dendritic spines is severely 
affected following chronic morphine treatment 
(33, 34). Chronic morphine treatment collapsed 
dendritic spines in hippocampal neuronal 
cultures, whereas treatment with DAMGO 
increased dendritic spine formation (35). As 
over-expression of Rac1 can induce the 
formation of dendritic spines (36), it is likely 
that selective activation of Rac1 by DAMGO, 
and not morphine, contributes to these 
morphological changes in neurons. We found 
that IQGAP1 was required for the DAMGO-
mediated increase in Rac1 activity. Consistent 
with this, previous studies have shown that 
IQGAP1 can bind Rac1 (and maintain it in the 
active, GTP-bound form), the actin 
cytoskeleton, and is necessary for dendritic 
spine formation in hippocampal neurons (20, 
37, 38). IQGAP1 is a large scaffolding protein 
that can interact with more than 90 proteins and 
MOR-interaction networks control spatiotemporal signaling 
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is therefore proposed to act as both “a junction 
(integrating receptor signals) and a node 
(diversifying signals to multiple outputs)” (20, 
38). In addition to integrating the signals of 
small GTPases (such as Rac1), IQGAP1 can 
constitutively bind other receptors, including 
the chemokine GPCRs, CXCR2 and CXCR4, 
and serves as a scaffold in the ERK signaling 
cascade by binding directly to Raf, MEK1/2 
and ERK1/2 (23, 38). This suggests that 
IQGAP1 could be a critical and specific 
scaffolding protein for MOR signaling in 
response to DAMGO, but not morphine. In 
addition to IQGAP1, we found that the 
scaffolding protein, CRKL was essential for 
increases in both Rac1 and ERK activity 
following DAMGO stimulation of the MOR. 
CRKL is an adaptor protein containing Src 
homology 2 (SH2) and SH3 protein-binding 
domains, allowing it to assemble protein 
complexes. CRK family adaptor proteins can 
increase the activity of Rac1 due to an SH3-
domain interaction with the Rac1 GEFs, 
DOCK180 and Sos (39), and CRKL can 
increase ERK activity dependent on Rac1 (23). 
The identification of both CRKL and IQGAP1 
as mediators of DAMGO-specific signaling of 
the MOR, shows that distinct ligands induce 
differential assembly of extensive MOR-
protein interaction networks. 
 
This concept is further supported by the unique 
protein-interaction networks that were 
identified following morphine stimulation of 
the MOR. Morphine stimulation of the MOR 
caused an enrichment of proteins implicated in 
the formation of desmosomes. Desmosomes 
are specialized regions of the plasma 
membrane. While the principle function of 
desmosomes is adhesion and maintenance of 
tissue integrity, they may also act as signaling 
hubs (16). In fact, activation of the delta opioid 
receptor (DOR) in keratinocytes has been 
shown to reorganize desmosomes in order to 
promote cell detachment and migration (40). 
Three protein families constitute the core 
components of desmosomes: transmembrane 
cadherin proteins, including desmogleins and 
desmocollins (DSGs, DSCs), armadillo 
proteins (plakoglobin or JUP and plakophilins) 
and desmoplakin (41). Plakoglobin (junction 
plakoglobulin or JUP,  g-catenin) binds to both 
desmogleins (DSGs) and desmocollins (DSCs) 
to assemble desmosomes (42, 43). Morphine 
stimulation of MOR caused an enrichment of 
biotinylated JUP, DSC1 and DSG1. 
Knockdown of DSC1 and JUP desmosomal 
proteins allowed the morphine-stimulated 
MOR to cause a transient increase in nuclear 
ERK. We previously reported a similar 
transformation of the morphine spatiotemporal 
signaling profile to mimic that of DAMGO (i.e. 
transient nuclear ERK), following inhibition of 
Gbg, PKC or disruption of the plasma 
membrane architecture (8). Interestingly, 
PKCa regulates the dynamics of desmosome 
assembly: inhibition of PKC decreases 
desmosome assembly (44), the translocation of 
desmoplakin to the plasma membrane depends 
on PKC (28) and PKC activation promotes 
desmosome fluidity (45).  
 
Desmosome assembly is a dynamic process 
involving clustering of DSC into nucleation 
sites, recruitment of DSG, followed by multiple 
phases of desmoplakin recruitment (46). While 
we, and others, have shown endogenous 
expression of desmosome component proteins 
in HEK293 cells (28, 47), these cells do not 
form mature desmoplakin-containing 
desmosomes (48). Desmosomes are found 
mainly in the epithelia and heart, however, 
hybrid junctions, that contain components of 
both adherens junctions and desmosomes, have 
been reported in cardiomyocytes, vascular 
endothelial cells and neurons (49, 50). Both 
desmosomes and adherens junctions are 
cadherin-based multiprotein complexes that 
couple cell-cell adhesion to the interfilament 
network (desmosomes) or the actin 
cytoskeleton (adherens junctions) (51). DSC 
and DSG have homology to the classical 
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cadherins (e.g. E-cadherin, N-cadherin) and 
JUP (plakoglobin, g-catenin) is highly 
homologous to b-catenin (51). In fact, 
exogenous expression of JUP can displace b-
catenin from adherens junctions (52), and in 
JUP knockout mice, b-catenin is incorporated 
into desmosomes (53). Neuronal synapses are 
adherens junctions that are specialised for 
chemical transmission (54). In this setting cell 
adhesion molecules, such as N-cadherin, 
maintain synaptic connections and can regulate 
the efficacy of synaptic transmission and 
plasticity (54, 55). JUP was associated with N-
cadherin at all stages of synapse development 
in cillary neurons (56) and together with 
desmoplakin, was identified bound to N-
cadherin in synapse-enriched lysate from 
hippocampal neurons (50). The authors 
proposed that the JUP/desmoplakin complex 
may tether cytoskeletal elements to a subset of 
synaptic junctions (50). Taken together, it 
seems clear that the desmosome-interaction 
network identified in HEK293 cells could also 
play an important role in MOR activation in 
neurons. Whether activation of MOR by 
morphine facilitates increased proximity of the 
receptor to classical desmosomes or a 
specialised hybrid junction (“desmosome-like 
platform”) is currently unknown. We propose 
that under normal conditions, morphine 
stimulation of the MOR activates a Gai/o-Gbg-
PKCa-phosphorylation pathway which 
stabilizes the formation of a desmosome-like 
platform in close proximity to MOR. This 
restricts MOR movement and limits the 
receptor to causing a sustained increase in 
cytosolic ERK. 
 
In conclusion, the use of APEX2 proximity 
biotinylation proteomics has allowed us to 
identify novel protein-interaction networks that 
are specific for DAMGO vs morphine 
stimulation of the MOR. This has provided 
mechanistic insights into previous observations 
of functional differences between these 
ligands. We found that DAMGO, but not 
morphine, can additionally activate Rac1 and 
identified IQGAP1 and CRKL as essential 
scaffolds and integrators of DAMGO-mediated 
signaling. Additionally, the distinct 
spatiotemporal signaling profile of morphine 
appears to be dependent on a Gai/o-Gbg-PKCa 
stabilization of a desmosome-like platform. 
This may restrict the distribution of the MOR 
at the plasma membrane to control sustained 
cytosolic ERK signaling. Knockdown of 
desmosomal proteins DSC1 or JUP likely 
released the MOR from this plasma membrane 
domain to facilitate a transient increase in 
nuclear ERK. Future studies will need to 
evaluate the relevance of these protein-
interactions in more complex systems and in 
vivo. Identifying MOR-interaction networks 
that control differential spatiotemporal 
signaling represents an important step towards 
understanding how compartmentalized 
signaling contributes to the beneficial and 
clinically limiting effects of opioid analgesics. 
 
 
EXPERIMENTAL PROCEDURES 
Drugs 
DAMGO was from Sigma-Aldrich and 
Morphine HCl was from GlaxoSmithKline. 
 
Constructs 
Mouse FLAG-MOR was from M. Christie 
(University of Sydney, Australia), FLAG-
MOR-APEX2 was from N. Veldhuis (Monash 
University, Australia). b-arrestin 2-Venus was 
from K. Pfleger (Harry Perkins Institute of 
Medical Research, Australia), KRas-RLuc8 
was from N. Lambert (Georgia Regents 
University, USA), GRK2 was from M Smit 
(Vrije Universiteit Amsterdam, The 
Netherlands). 
 
CAMYEL was from ATCC. cytoEKAR 
EGFP-mRFP (Addgene plasmid 18680) and 
nucEKAR EGFP-mRFP (Addgene plasmid 
18682) were from K. Svoboda (25). RaichuEV-
Rac1 and Raichu-Cdc42/Cdc42CT (21, 22) 
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were from M. Matsuda and K. Aoki (Kyoto 
University, Japan) and are contained in the 
pCAGGS vector (57) from J. Miyazaki (Osaka 
University, Japan). 
 
Antibodies 
Immunostaining (confocal microscopy), 
immunoblotting and in-cell westerns were 
performed using primary antibodies 
recognizing β-arrestin 1/2 (Cell Signaling 
Technology 46745; rabbit, 1:1000), β-actin 
(Cell Signaling Technology 3700S; mouse, 
1:5000),  a-tubulin (Cell Signaling 
Technology 3873; mouse, 1:4000), β-tubulin 
(Cell Signaling Technology 2146S; rabbit, 
1:500), GRK2 (Santa Cruz Biotechnology sc-
562; rabbit, 1:200), Rac1 (Millipore 05-389; 
mouse, 1:4000), DSC1 (Abcam ab150382; 
rabbit, 1:1000), DSG1 (Abcam ab124798; 
rabbit, 1:1000), IQGAP1 (Abcam ab86064; 
rabbit, 1:2000), JUP (Abcam ab184919; rabbit, 
1:1000), CRKL (Abcam ab151791; rabbit, 
1:1000), FLAG M2 for confocal microscopy 
(Sigma-Aldrich F3165; mouse, 1:1000), FLAG 
M2 for in-cell westerns (Sigma-Aldrich F3165; 
mouse, 1:200). 
 
Primary antibodies were detected using the 
following fluorescent secondary antibodies: 
goat anti-mouse 680 (LI-COR 926-68070; 
1:10,000 for immunoblotting or 1:800 for in-
cell westerns), goat anti-rabbit 800 (LI-COR 
926-32211; 1:10,000 for immunoblotting or 
1:800 for in-cell westerns), goat anti-mouse 
AlexaFluor 488 (ThermoFisher Scientific 
A28175; 1:500 for confocal microscopy). 
Endogenous Rac1 and  a-tubulin 
(immunoblotting) were detected using a HRP-
linked antibody (Cell Signaling Technology 
7076; mouse, 1:4000). 
 
Cell Culture and Transfection 
HEK293 cells (ATCC, negative for 
mycoplasma contamination) were grown in 
Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 5% (v/v) fetal 
bovine serum (FBS). All assay dishes and 
plates were coated with poly-D-lysine (5 
ug/cm2). HEK293 cells were transfected using 
linear polyethyleneimine (PEI) (58). 
 
RNA-seq 
RNA was extracted from two passages of 
HEK293 cells (P0 and P37) using the RNeasy 
Mini Kit (Qiagen), and transcriptome 
sequencing was performed by the Beijing 
Genomics Institute. 
 
Confirmation of Target Knockdown by siRNA 
HEK293 cells in 6-well pates were transfected 
with 25 nM scrambled, IQGAP1, CRKL, 
DSC1 or JUP SMARTpool ON-TARGETplus 
siRNA (GE Dharmacon) for 48 hours 
(quantitative RT-PCR) or 72 hours 
(immunoblotting). Immunoblotting was used 
to confirm knockdown at the protein level for 
IQGAP1, CRKL and JUP. DSC1 was not 
detectable by immunoblotting due to low 
expression in HEK293 cells (Figure S8), so we 
used quantitative RT-PCR to confirm 
knockdown. 
 
For confirmation of knockdown by 
immunoblotting, cells were lysed by 
resuspending in RIPA buffer (150 mM NaCl, 
1% v/v NP-40, 0.5% w/v sodium deoxycholate, 
0.1% w/v SDS, 50 mM Tris-Cl pH 8.0; 
supplemented with 1 mM EDTA and protease 
mini EDTA-free inhibitor cocktail [Roche]) 
and incubating for 30 min on ice. The samples 
were sonicated on ice (30 s at 30% amplitude; 
Qsonica Q125), centrifuged (10,000xg for 10 
min at 4°C), the supernatants mixed with 
Laemmli sample buffer and incubated at 95°C 
for 5 min. Samples were stored at -80°C prior 
to immunoblotting. 
 
For confirmation of knockdown by quantitative 
RT-PCR, RNA was extracted from HEK293 
cells using the RNeasy Mini Kit (Qiagen). 
Quantitative RT-PCR was performed in 
duplicate from 500 ng of RNA. cDNA was 
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produced using iScript Reverse Transcription 
Supermix (BioRad) and 2720 Thermal Cycler 
(Applied Biosystems). Quantitative PCR used 
the TaqMan Fast Advanced Master Mix 
(Invitrogen) and a CFX384 Real-time System 
C1000 Touch (BioRad). TaqMan probes 
(Applied Biosystems) used in this study were 
as follows: DSC1 (Hs00245189_m1), and 
HPRT1 (Hs02800695_m1). The 2-DCt method 
(59) was used to analyze results, and data are 
expressed as 2-DCt (difference in Ct values of the 
gene of interest relative to the housekeeping 
gene, HPRT1) from 6 biological replicates. 
 
Measurement of Endogenous Rac1 Protein 
HEK293 cells in 6-well pates were transfected 
with 25 nM scrambled, IQGAP1 or CRKL 
SMARTpool ON-TARGETplus siRNA (GE 
Dharmacon) for 72 hours. Cells were lysed by 
resuspending in ice-cold buffer (150 mM NaCl, 
10 mM MgCl2, 1% v/v NP-40, 0.1% w/v SDS, 
50 mM Tris pH 7.5, 1 mM PMSF, protease 
inhibitor cocktail), incubating for 10 min on 
ice, then passing through a 21G needle 30 
times. The samples were centrifuged (400xg 
for 3 min at 4°C), the protein in the supernatant 
quantified using a Bradford protein assay, and 
supernatants mixed with Laemmli sample 
buffer. Samples were stored at -80°C prior to 
immunoblotting (50 µg total protein per lane). 
 
Immunoblotting: confirmation of protein 
knockdown 
Proteins were resolved by SDS–
polyacrylamide gel electrophoresis (SDS-
PAGE) using precast 4-15% Mini-PROTEAN 
TGX gels (Bio-Rad) and transferred to 0.45-
mm LF PVDF (low fluorescence 
polyvinylidene difluoride) membranes (Bio-
Rad) using a Trans-Blot SD Semi-Dry Transfer 
Cell (for 75 min at 10 V; Bio-Rad). Membranes 
were blocked for 1 hour at room temperature 
(5% w/v BSA in PBS with 0.1% v/v Tween 20 
[PBS-T]) and incubated with primary antibody 
overnight at 4°C (diluted in 1% w/v BSA). 
Membranes were washed, incubated with 
secondary antibody (diluted in PBS-T) for 1 
hour at room temperature, and washed. 
Immunoreactivity was detected by 
fluorescence using the Odyssey Classic 
Infrared Imager (LI-COR Biosciences), with 
resolution set at 169 μm. 
 
Immunoblotting: endogenous Rac1 protein 
Proteins were resolved by SDS-PAGE using 
15% gels and transferred to 0.45 µm 
nitrocellulose membranes (Amersham) using a 
Mini Trans-Blot Electrophoretic Transfer Cell 
(for 1 hour at 100 V; Bio-Rad). Membranes 
were blocked for 1 hour at room temperature 
(5% w/v skim milk in Tris-Buffered Saline 
[TBS] with 0.2% v/v Tween-20 [TBS-T]) and 
incubated with primary antibody overnight at 
4°C (diluted in 1% w/v skim milk). Membranes 
were washed, incubated with secondary 
antibody (diluted in TBS-T) for 1 hour at room 
temperature, and washed before a final wash in 
TBS. Immunoreactivity was detected by 
enhanced chemiluminescence using ECL 
Prime Western Blotting System (GE 
Healthcare).  
 
In-Cell Western Assay 
HEK293 cells were transfected with 55 ng/well 
FLAG-MOR or FLAG-MOR-APEX2 in black, 
optically clear 96-well plates. Following 
transfection, the cells were fixed with 4% (v/v) 
paraformaldehyde in PBS (20 min at room 
temperature) and then either left intact or 
permeabilized in 0.1% (v/v) Triton X-100 in 
PBS (three 10 min washes at room 
temperature). The cells were blocked (5% w/v 
BSA in PBS, with 0.1% v/v Tween-20 added to 
permeabilized samples) for 2 hr at room 
temperature followed by overnight incubation 
with primary antibodies at 4°C (diluted in 1% 
w/v BSA in PBS, with 0.1% v/v Tween-20 
added to permeabilized samples). After 
washing (three 5 min washes with PBS, with 
0.1% v/v Tween-20 added to permeabilized 
samples), the cells were incubated with 
secondary antibodies for 1 hour in the dark at 
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room temperature (diluted in 1% w/v BSA in 
PBS, with 0.5% v/v Tween-20 added to 
permeabilized samples). The cells were washed 
(three 5 min washes with PBS at room 
temperature, with 0.1% v/v Tween-20 added to 
permeabilized samples), the buffer aspirated, 
and the dry plate was scanned using the 
Odyssey Classic Infrared Imager (LI-COR 
Biosciences), with resolution set at 169 μm and 
offset at 3 mm.  
 
Confocal Imaging 
Cells expressing FLAG-MOR or FLAG-MOR-
APEX2 were fixed with 4% (w/v) PFA in PBS 
for 20 min at 4°C and then were washed three 
times for 5 min with PBS. Cells were blocked 
in PBS containing 3% (v/v) normal goat serum 
and 0.1% (w/v) saponin for 1 hour at room 
temperature and then were incubated with 
primary antibody in PBS containing 1% (v/v) 
normal horse serum and 0.1% (w/v) saponin 
overnight at 4°C. Cells were washed three 
times for 5 min with PBS and incubated with 
secondary antibody in PBS containing 1% (v/v) 
normal horse serum and 0.1% (w/v) saponin for 
2 hours at room temperature. The cells were 
washed three times for 5 min in PBS before the 
addition of 1 µg/mL DAPI nuclear stain for 5 
min at room temperature in the dark. Cells were 
washed twice for 5 min with PBS. To visualize 
the localization of FLAG-MOR or FLAG-
MOR-APEX2, cells were observed with a 
Leica SP8 confocal microscope and HCX PL 
APO 63Å~ CS2 (NA, 1.40) oil objective. 
 
BRET Assays: cAMP and b-arrestin 
recruitment 
HEK293 cells in 10 cm dishes were co-
transfected with 2 μg FLAG-MOR or FLAG-
MOR-APEX2 and 1 μg CAMYEL (BRET 
cAMP biosensor). For b-arrestin recruitment 
assays, HEK293 cells in 10 cm dishes were co-
transfected with 1 μg FLAG-MOR or FLAG-
MOR-APEX2, 1 μg KRas-RLuc8, 2 μg GRK2, 
and 4  µg β-arrestin 2-Venus. After 24 hours, 
the cells were re-plated in 96-well white 
opaque plates (CulturPlate, PerkinElmer). 
Forty-eight hours after transfection, the 
medium was removed and cells were washed 
once with Hank’s balanced salt solution 
(HBSS, Gibco), before incubation of the cells 
in HBSS for 30 min at 37˚C. For cAMP assays, 
the cells were incubated with 5 μM 
coelenterazine h (NanoLight) in the dark for 10 
min at 37˚C, before co-addition of 30 μM 
forskolin (to activate adenylyl cyclase) and 
vehicle (0.1% v/v DMSO) or increasing 
concentrations of DAMGO for 5 min at 37˚C.  
b-arrestin recruitment assays measured the 
proximity of b-arrestin 2-Venus to KRas-
RLuc8 (a marker of the plasma membrane), 
which allowed direct comparison of the effects 
of activation of MOR vs MOR-APEX2 in the 
same assay system. Co-expression of GRK2 
ensured a detectable b-arrestin 2-Venus/KRas-
RLuc8 BRET signal (7, 60). For b-arrestin 
recruitment assays, 5 μM coelenterazine h was 
added to the cells and the BRET baseline was 
measured every minute for 15 min, before 
addition of vehicle (0.1% v/v DMSO) or 1 µM 
DAMGO with BRET measurements continued 
every 1 min for 20 min. BRET was measured 
using a LUMIstar OMEGA plate reader (BMG 
Labtech) with sequential integration of the 
signals detected at 475±30 nm and 535±30 nm 
with filters with the appropriate band pass. 
Data are shown as the BRET ratio (calculated 
as the ratio of the YFP signal to the RLuc 
signal) expressed as the ligand-induced change 
in BRET compared to 30 μM forskolin alone 
for the cAMP assay, or as the 20 min area under 
the curve (AUC) following baseline correction 
for the b-arrestin recruitment assay. 
 
Spatial ERK and Rac1 using High-Content 
Ratiometric FRET Imaging 
Ratiometric FRET imaging was performed as 
described previously (8, 10). We detected 
changes in ERK using EKAR targeted to the 
cytosol or the nucleus, which undergoes a 
conformational change after ERK 
phosphorylation of a target sequence (25). 
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Changes in Rac1 and Cdc42 activity were 
detected using RaichuEV-Rac1 or Raichu-
Cdc42, respectively, which undergo a 
conformational change after GTP displaces 
guanosine diphosphate (GDP) within a target 
sequence (21, 22). 
 
HEK293 cells were seeded in black, optically 
clear 96-well plates and grown to 70% 
confluency before co-transfection with FLAG-
MOR or FLAG-MOR-APEX2 (55 ng per well) 
and a FRET biosensor (40 ng per well). For 
experiments with siRNA, HEK293 cells were 
co-transfected with an additional 25 nM 
scrambled, CRKL, IQGAP1, JUP or DSC1 
SMARTpool ON-TARGETplus siRNA (GE 
Dharmacon) for 72 hours. Before the 
experiment, HEK293 cells were partially 
serum restricted overnight in 0.5% (v/v) FBS 
DMEM. Fluorescence imaging was performed 
using a high-content GE Healthcare INCell 
2000 Analyzer with a Nikon Plan Fluor ELWD 
40× (NA, 0.6) objective and FRET module as 
previously described (Halls et al 2015). For 
CFP/YFP (RaichuEV-Rac1 and Raichu-
Cdc42) emission ratio analysis, cells were 
sequentially excited using a CFP filter (430 
nm/24 nm) with emission measured using YFP 
(535 nm/30 nm) and CFP (470 nm/24 nm) 
filters and a polychroic filter optimized for the 
CFP/YFP filter pair (Quad3). For GFP/RFP 
(cytoEKAR and nucEKAR) emission ratio 
analysis, cells were sequentially excited using 
a fluorescein isothiocyanate (FITC) filter (490 
nm/20 nm) with emission measured using 
dsRed (605 nm/52 nm) and FITC (525 nm/ 36 
nm) filters and a polychroic filter optimized for 
the FITC/dsRed filter pair (Quad4). For control 
experiments (Figure 1, S2), cells were imaged 
every 1 min for 20 min (image capture of 14 
wells per min); for experiments using siRNA, 
cells were imaged every 1.5 min for 21 min 
(imaged capture of 18 wells per min). At the 
end of each experiment, the same cells were 
stimulated with the following positive controls 
to maximally activate the biosensor: 200 nM 
phorbol 12,13-dibutyrate (PDBu) for EKAR, 
or a cocktail of 1 µM isoprenaline, 50 ng/ml 
EGF, 10 µM AlCl3, and 10 mM NaF for 
RaichuEV-Rac1 and Raichu-Cdc42 (Halls et 
al. 2015). Only HEK293 cells with >5% 
change in F/F0 (FRET ratio relative to baseline 
for each cell) after stimulation with positive 
controls were selected for analysis, and the data 
were expressed relative to the positive control 
(F/FMax). The average F/FMax was calculated for 
each experiment, and combined. Data were 
analyzed using in-house scripts written for the 
FIJI distribution of ImageJ (61), as previously 
described (58).  
 
APEX2 Proximity Biotinylation: sample 
preparation 
For analysis by immunoblotting, HEK293 cells 
in 3.5 mm dishes were transfected with 1 µg 
FLAG-MOR-APEX2. For analysis by mass 
spectrometry, HEK293 cells in 10 cm dishes 
were transfected with 5 µg FLAG-MOR-
APEX2, with three plates used for each 
experimental condition. 48 hours post-
transfection, the media was replaced with that 
containing 500 μM biotin-tyramide (Iris 
Biotech GmbH) and incubated for 1 hour. 
During this time, the cells were treated with 
either vehicle (0.1% v/v DMSO), 1 μM 
DAMGO or 1 μM morphine (mass 
spectrometry analysis only) for the indicated 
time. Biotin-labelling was initiated by addition 
of 1 mM H2O2 for 1 min. The media was 
removed, the cells were placed on ice, washed 
three times with ice-cold quenching buffer (10 
mM sodium ascorbate, 5 mM Trolox, 10 mM 
sodium azide in PBS), then incubated in 
quenching buffer for 20 min. The quenching 
buffer was removed and the cells were scraped 
in lysis buffer (50 mM Tris-HCl pH 7.4, 500 
mM NaCl, 0.2% w/v SDS, protease mini 
EDTA-free inhibitor cocktail [Roche], 1 mM 
DTT). The lysates were transferred to conical 
tubes containing pre-chilled 20% (v/v) Triton 
X-100 in 50 mM Tris-HCl pH 7.4. The samples 
were sonicated on ice (five 30 s on/off cycles at 
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50% amplitude; Qsonica Q125), centrifuged 
(16,000xg for 10 min at 4°C) and the 
supernatants were incubated with either 25 μL 
(immunoblotting) or 100 μL (mass 
spectrometry) streptavidin magnetic beads 
(ThermoFisher Scientific) overnight at 4°C. 
 
After magnetic separation (3 min at room 
temperature), the supernatant was removed and 
beads were washed with wash buffer 1 (2% w/v 
SDS) for 8 min at room temperature. The 
samples were again separated on a magnetic 
stand (3 min at room temperature) and then 
washed once with wash buffer 2 (0.1% w/v 
deoxycholic acid, 1% v/v Triton X-100, 1 mM 
EDTA, 500 mM NaCl, 50 mM HEPES, pH 7.5) 
followed by wash buffer 3 (0.5% w/v 
deoxycholic acid, 0.5% v/v NP-40, 1 mM 
EDTA, 250 mM LiCl, 10 mM Tris-HCl, pH 
7.4) and then final two washes with 100 mM 
HEPES pH 8.1. For immunoblotting, the 
proteins were eluted in Laemmli buffer by 
boiling for 15 min. For mass spectrometry, the 
proteins were eluted in FASP lysis buffer (100 
mM Tris pH 7.6, 4% w/v SDS, 100 mM DTT) 
at 95°C for 15 min. The supernatant was 
digested with trypsin using the FASP Protein 
Digestion Kit (Expedeon) overnight at 37°C. 
Digested peptides were desalted using ZipTips 
(Merck Millipore). Samples were eluted (70% 
v/v acetonitrile, 0.1% v/v formic acid) and then 
dried by SpeedVac (Labconco). Samples were 
resuspended (2% v/v acetonitrile, 1% v/v 
formic acid, 33 nM iRT peptides) by sonication 
at 37°C for 10 min before LC-MS/MS. 
 
APEX2 Proximity Biotinylation: experimental 
design and statistical rationale 
HEK293 cells were transfected with MOR-
APEX2 and stimulated with the indicated 
treatments (vehicle, DAMGO, morphine) for 
10 min or 60 min on three independent 
occasions (four biological replicates, 6 samples 
in each replicate). Time-matched vehicle 
treated samples were used as controls. Peptide 
and protein searches were performed using 
MaxQuant at a FDR threshold of 1% (described 
in detail below). The fourth replicate was 
removed from further analysis due to a 
consistently low number of proteins identified 
across all experimental conditions. All 374 
identified proteins were input for Ingenuity 
Pathway Analysis (described in detail below). 
The statistical significance of the ligand-
induced change in log2 for proteins of interest 
was determined by two-way ANOVA with 
Dunnett’s multiple comparison test. 
 
APEX2 Proximity Biotinylation: LC-MS/MS 
Using a Dionex UltiMate 3000 RSLCnano 
system equipped with a Dionex UltiMate 3000 
RS autosampler, an Acclaim PepMap RSLC 
analytical column (75 µm x 50 cm, nanoViper, 
C18, 2 µm, 100Å; Thermo Scientific) and an 
Acclaim PepMap 100 trap column (100 µm x 2 
cm, nanoViper, C18, 5 µm, 100Å; Thermo 
Scientific), the tryptic peptides were separated 
by increasing concentrations of 80% ACN / 
0.1% formic acid at a flow of 250 nl/min for 
120 min and analysed with a QExactive Plus 
mass spectrometer (Thermo Scientific) 
operated in data-dependent acquisition mode 
using in-house, LFQ-optimized parameters.  
 
In detail, the eluent was nebulised and ionised 
using a nano electrospray source with a distal 
coated fused silica emitter (New Objective). 
The capillary voltage was set at 1.7 kV. The Q 
Exactive mass spectrometer was operated in 
the data dependent acquisition mode to 
automatically switch between full MS scans 
and subsequent MS/MS acquisitions. Survey 
full scan MS spectra (m/z 375–1575) were 
acquired in the Orbitrap with 70,000 resolution 
(at m/z 200) after accumulation of ions to a 3 x 
106 target value with a maximum injection time 
of 54 ms. Dynamic exclusion was set to 15 s. 
The 12 most intense multiply charged ions (z ≥ 
2) were sequentially isolated and fragmented in 
the collision cell by higher-energy collisional 
dissociation (HCD) with a fixed injection time 
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of 54 ms, 17,500 resolution and automatic gain 
control (AGC) target of 2 x 105.  
 
APEX2 Proximity Biotinylation: peptide and 
protein identification 
Acquired .raw files were analysed with 
MaxQuant v1.6.0.16 (62) to identify and 
quantify peptides and proteins using the human 
SwissProt database downloaded from Uniprot 
in November 2017. The database, which 
contained 20,243 entries, was appended by the 
iRT peptide sequences. The parameters for 
MaxQuant searches were as follows: precursor 
mass tolerance was set to 20 ppm (parts per 
million) for the first search and 4.5 ppm for the 
main search. Carbamidomethylation of 
cysteines was entered as a fixed modification, 
while oxidation of methionines and acetylation 
of protein N-termini were set as variable 
modifications. Trypsin was used as the 
enzymatic protease and a maximum of two 
missed cleavages was allowed. The false 
discovery rate (FDR) for peptide and protein 
identification was set to 1%, using the target-
decoy approach and only unmodified and razor 
peptides were used for quantification. Label-
free quantification was switched on with 
minimum peptide ratio count of 2. The 
ProteinGroups.txt file generated by MaxQuant 
was further analyzed with Perseus v1.6.0.7 (63) 
after proteins that were identified “only-by-
site”, reverse hits and potential contaminants 
were removed. 
 
APEX2 Proximity Biotinylation: Ingenuity 
Pathway Analysis 
IPA (version 01-14) (64) requires values in all 
the experimental conditions input for analysis. 
To maximize the proteins included in this 
analysis, we performed two rounds of 
imputation to generate values where a signal 
was not detected for all experimental 
conditions. 
 
First, a fixed log2 value of 16 was imputed for 
the missing experimental conditions when a 
protein was not identified in vehicle-treated 
samples but was found in samples treated with 
either DAMGO or morphine or both, and vice 
versa. The value used was smaller than the 
lowest log2 value identified from all 374 
proteins (log2 of 17.1). This allowed us to keep 
proteins in the dataset that are either recruited 
to MOR or move away from MOR following 
stimulation. The second imputation step was 
for missing values for proteins that were not 
detected in every biological replicate. 
 
In this case, the missing values were subjected 
to several rounds of imputation with Perseus 
v.1.6.0.7 to define the optimal imputation 
parameters. The missing values were randomly 
replaced from a normal distribution by varying 
the parameters for width (of the Gaussian 
distribution relative to the standard deviation of 
measured values) and down shift (of the 
Gaussian distribution used for the random 
numbers). It is important that the imputed 
values meet three criteria: they do not form a 
separate normal distribution, they start at 
approximately the same point for all biological 
replicates, and the distribution is narrower than 
that of the measured values. We found a 0.5 
width and 1.5 downshift were the best-fit 
parameters across all replicates. 
 
All values (experimental and imputed) from the 
three biological replicates were expressed as 
average log2 change compared to vehicle 
treated controls. These values were imported 
into IPA for analysis. First, a core analysis was 
performed to quickly identify relationships, 
mechanisms, functions and pathways specific 
to a particular treatment condition (i.e. 
DAMGO 10 or 60 min, morphine 10 or 60 
min). Second, a comparison between the four 
treatment conditions was performed to allow 
prediction of activation/inhibition of canonical 
pathways and generation of networks of 
interacting proteins. This allowed us to 
generate protein-interaction network heat maps 
(Figures 2B, 3A and 4A and Tables 1-3). 
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Statistical analysis was performed without 
imputed values (Figure 2C, 3C and 4C). 
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FOOTNOTES 
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 
(65) partner repository with the dataset identifier PXD013328. 
 
Abbreviations 
APEX2 ascorbate peroxidase from the soy bean 
BRET  bioluminescence resonance energy transfer 
CRKL  Crk-like protein 
DAMGO [D-Ala2,N-MePhe4,Gly-ol]-enkephalin 
DSC1  desmocolin-1 
DSG1  desmoglein-1 
ERK  extracellular signal regulated kinase 
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FRET  Förster resonance energy transfer 
GPCR  G protein-coupled receptor 
GRK2  G protein receptor kinase 2 
IPA  Ingenuity Pathway Analysis software 
IQGAP1 IQ motif containing GTPase activating protein 1 
JUP  junction plakoglobin 
MOR  mu opioid receptor 
PKC  protein kinase C 
Rac1  Ras-related C3 botulinum toxin substrate 1 
 
 
TABLES 
 
Table 1. Proteins from interaction networks important for endocytosis. The proteins and 
average log2 values are listed for the endocytic protein-interaction network shown as a heat map 
in Figure 2B. Biotinylated proteins in HEK293 cells transiently expressing MOR-APEX2 were 
isolated and identified following stimulation with vehicle, DAMGO or morphine for 60 min. Data 
are expressed as the log2 change compared to vehicle. 
  Log2 value 
Gene name Protein name DAMGO morphine 
ACTN4 actinin alpha 4 0.395 -0.296 
ANXA5 annexin A5 0.379 0.224 
ARF1 ADP ribosylation factor 1 0.235 -0.104 
ATP5F1B ATP synthase F1 subunit beta 0.113 -0.244 
CANX calnexin 1.056 0.091 
CKB creatine kinase B 0.928 0.352 
CLTC clathrin heavy chain 0.652 -0.146 
CTTN cortactin 0.775 0.201 
EZR ezrin 0.11 -0.868 
FLNA filamin A 0.356 -0.069 
HNRNPK heterogeneous nuclear ribonucleoprotein K -0.102 -0.539 
HSP90AA1 heat shock protein 90 alpha family class A member 1 -0.147 -0.678 
HSPA5 heat shock protein family A (Hsp70) member 5 0.795 0.379 
IQGAP1 IQ motif containing GTPase activating protein 1 1.165 0 
MYH9 myosin heavy chain 9 -0.129 -0.489 
NCL nucleolin -0.359 -0.651 
NPM1 nucleophosmin 1 -0.159 -0.475 
PACSIN2 protein kinase C and casein kinase substrate in 
neurons 2 -0.735 0 
PFN1 profilin 1 0.054 -0.24 
RAB5C RAB5C, member RAS oncogene family 0.426 0.209 
RAB7A RAB7A, member RAS oncogene family 0.294 -0.432 
RACK1 receptor for activated C kinase 1 -0.049 -0.193 
RUVBL2 RuvB like AAA ATPase 2 0.5 -0.144 
S100A9 S100 calcium binding protein A9 -0.972 -0.139 
TFRC transferrin receptor -0.52 -0.744 
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VIM vimentin -0.161 -0.591 
 
 
Table 2. Proteins from interaction networks important for DAMGO signaling. The proteins 
and average log2 values are listed for interaction networks important for actin cytoskeletal 
signaling, signaling by Rho family GTPases and integrin signaling shown as a heat map in Figure 
3A. Biotinylated proteins in HEK293 cells transiently expressing MOR-APEX2 were isolated and 
identified following stimulation with vehicle, DAMGO or morphine for 60 min. Data are 
expressed as the log2 change compared to vehicle. 
  Log2 value 
Gene 
name 
Protein name DAMGO morphine 
CFL1 cofilin 1 -0.366 -0.799 
VCL vinculin -0.335 -1.117 
VIM vimentin -0.161 -0.591 
ACTB actin beta -0.134 -0.434 
MYH9 myosin heavy chain 9 -0.129 -0.489 
RACK1 receptor for activated C kinase 1 -0.049 -0.193 
PFN1 profilin 1 0.054 -0.764 
EZR ezrin 0.11 -0.868 
ARF1 ADP ribosylation factor 1 0.235 -0.104 
FLNA filamin A 0.356 -0.069 
ACTN4 actinin alpha 4 0.395 -0.296 
CTTN cortactin 0.775 0.201 
CRKL CRK like proto-oncogene, adaptor protein 0.893 -0.068 
IQGAP1 IQ motif containing GTPase activating protein 1 1.165 0 
FN1 fibronectin 1 3.494 0 
 
 
Table 3. Proteins from interaction networks important for morphine signaling. The proteins 
and average log2 values are listed for interaction networks identified as important for morphine 
signaling shown as a heat map in Figure 4A. Biotinylated proteins in HEK293 cells transiently 
expressing MOR-APEX2 were isolated and identified following stimulation with vehicle, 
DAMGO or morphine for 60 min. Data are expressed as the log2 change compared to vehicle. 
  Log2 value 
Gene 
name 
Protein name DAMGO morphine 
ACP1 acid phosphatase 1 0.175 -0.154 
ALDOA aldolase, fructose-bisphosphate A -0.437 -0.596 
ANXA7 annexin A7 0.107 0.084 
ARF1 ADP ribosylation factor 1 0.235 -0.104 
CASP14 caspase 14 -0.524 0.144 
CDV3 CDV3 homolog 0.185 -0.149 
CTSD cathepsin D 1.147 1.523 
DDOST 
dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase non-catalytic subunit 0.27 -0.017 
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DSC1 desmocollin 1 -0.09 0.451 
DSG1 desmoglein 1 0.101 0.658 
ELAVL1 ELAV like RNA binding protein 1 -0.126 -0.292 
FABP5 fatty acid binding protein 5 0.418 0.192 
IMPDH2 inosine monophosphate dehydrogenase 2 0.694 -0.086 
JUP junction plakoglobin -0.119 0.352 
MAP4 microtubule associated protein 4 0.049 -0.138 
NEFL neurofilament light -0.264 -0.484 
NEFM neurofilament medium -0.113 -0.641 
OCLN occludin 0.527 0 
PARP1 poly(ADP-ribose) polymerase 1 -0.289 -0.498 
RAB7A RAB7A, member RAS oncogene family 0.294 -0.432 
RACK1 receptor for activated C kinase 1 -0.049 -0.193 
RAN RAN, member RAS oncogene family -0.492 -0.667 
RCC2 regulator of chromosome condensation 2 0.057 0.181 
VIM vimentin -0.161 -0.591 
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Figure 1. Using APEX2 proximity biotinylation proteomics to identify novel MOR-
interaction networks. A. Addition of an APEX2 tag to the C-terminus of the MOR allows 
biotinylation of interacting and proximal proteins (within 20 nm) following addition of biotin-
tyramide to the cell culture medium, and activation of the APEX2 enzyme by hydrogen peroxide. 
After the reaction is quenched, cells are lysed, the biotinylated proteins are isolated by streptavidin 
pulldown and identified by mass spectrometry. B. In-cell western showing cell surface expression 
of MOR wild-type (MOR) and APEX2-tagged (MOR-APEX2) transiently expressed in HEK293 
cells (n=3). C. Inhibition of forskolin-stimulated cAMP following DAMGO stimulation of 
HEK293 cells transiently expressing MOR or MOR-APEX2 and a BRET biosensor for cAMP 
(n=3). D. Recruitment of b-arrestin 2-Venus to KRas-RLuc8 in HEK293 cells co-expressing 
GRK2 and MOR (control) or MOR-APEX2 in response to stimulation with 1 µM DAMGO was 
determined using BRET (n=3). Data are expressed as the 20 min area under the curve. E-H. 
Analysis of the spatial activation of ERK in HEK293 cells transiently expressing MOR or MOR-
APEX2 and stimulated with vehicle, 10 nM DAMGO or 100 nM morphine. E. Analysis of 
cytosolic ERK activity using cytoEKAR (n= 3). F. AUC from E, and Figure S2A. G. Analysis of 
nuclear ERK activity using nucEKAR (n=3). H. AUC from G and Figure S2B. ** p<0.05, *** 
p<0.001 versus vehicle control, two-way ANOVA with Dunnett’s multiple comparison test. I. 
Analysis of the proximity of MOR-APEX2 to transiently expressed GRK2 in HEK293 cells 
following stimulation with 1 µM DAMGO, streptavidin pulldown and immunoblotting. Scatter 
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plots show individual data points, symbols/bars represent means and error bars indicate standard 
deviation of the mean from n experiments as stated. 
 
 
 
 
 
Figure 2. Stimulation of MOR-APEX2 with DAMGO, but not morphine, identifies protein-
networks important for endocytosis. A. Stimulation of HEK293 cells transiently expressing 
MOR-APEX2 with vehicle, 1 µM DAMGO or 1 µM morphine for 10 or 60 min identified 374 
biotinylated proteins. The Venn diagrams indicate the number of proteins that were significantly 
enriched for each treatment condition (>1.5 fold change compared to vehicle control, or present in 
stimulated samples but absent in vehicle-treated samples and vice versa), including the number of 
unique proteins and the number of proteins that were identified in multiple treatment conditions. 
D10, DAMGO 10 min; D60, DAMGO 60 min; M60, morphine 60 min; and M10, morphine 10 
min. B-D. As expected, stimulation of MOR-APEX2 with DAMGO, but not morphine, enriched 
proteins that are important in endocytic networks, as determined by Ingenuity Pathway Analysis 
(IPA) software. B. Heat map showing proteins from the endocytic network that were increased 
(orange) or decreased (purple) following stimulation of MOR-APEX2 with DAMGO or morphine 
for 60 min compared to a vehicle control. Data are expressed as the average log2 change in protein 
abundance compared to vehicle (n=3). C. Proteins from B that were differentially affected by 
DAMGO vs morphine treatment. Data are expressed as the log2 change in protein abundance 
compared to vehicle control, with scatter plots showing the individual data points, bars 
representing the mean and error bars indicating the standard deviation of the mean of three 
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independent experiments. * p<0.05, ** p<0.01 and *** p<0.001 versus vehicle control, two-way 
ANOVA with Dunnett’s multiple comparison test. 
 
 
 
Figure 3. DAMGO, but not morphine, activates Rac1 and its spatiotemporal signaling profile 
is dependent on the scaffolding proteins IQGAP1 and CRKL. A-C. Stimulation of MOR-
APEX2 with DAMGO, but not morphine, for 60 min enriched proteins involved in actin 
cytoskeleton signaling, signaling by Rho family GTPases and integrin signaling (n=3). A. Heat 
map showing proteins from these three pathways that were increased (orange) or decreased 
(purple) following treatment with DAMGO or morphine compared to a vehicle control. Data are 
expressed as the average log2 change in protein abundance compared to vehicle. B. The interaction 
networks for the proteins that were differentially affected by DAMGO (left panel) vs morphine 
(right panel) were determined by IPA. Red indicates increased abundance, whereas green indicates 
a decrease. Data are expressed as the average log2 change in protein abundance compared to a 
MOR-interaction networks control spatiotemporal signaling 
 27 
vehicle control. C. Proteins from B, with data expressed as the log2 change in protein abundance 
compared to vehicle control. * p<0.05, ** p<0.01 and *** p<0.001 versus vehicle control, two-
way ANOVA with Dunnett’s multiple comparison test. D-J. Analysis of the activation of Rac1 in 
single HEK293 cells transiently expressing MOR and RaichuEV-Rac1 and stimulated with 
vehicle, 1 μM DAMGO or 1 μM morphine. D. Time course of Rac1 activity (n=3). E. AUC of 
data from D, F, G and I. *** p<0.001 versus vehicle control, two-way ANOVA with Dunnett’s 
multiple comparison test. F. Time course of Rac1 activity in cells co-transfected with scrambled 
siRNA (n=3). G. Time course of Rac1 activity in cells co-transfected with IQGAP1 siRNA (n=3). 
H. Confirmation of knockdown of IQGAP1 protein by immunoblotting. Left panel is a 
representative blot, right panel is the grouped intensity measurements from 4 independent 
experiments. ** p<0.01 versus pcDNA transfected control, one-way ANOVA with Dunnett’s 
multiple comparisons test. I. Time course of Rac1 activity in cells co-transfected with CRKL 
siRNA (n=3). J. Confirmation of knockdown of CRKL protein by immunoblotting. Left panel is 
a representative blot, right panel is the grouped intensity measurements from 3 independent 
experiments. * p<0.05 versus pcDNA transfected control, one-way ANOVA with Dunnett’s 
multiple comparisons test. K. AUC of nuclear ERK measured in single HEK293 cells transiently 
expressing MOR and nucEKAR, and stimulated with vehicle, 1 μM DAMGO or 1 μM morphine, 
under control conditions or following co-transfection with scrambled siRNA, IQGAP1 siRNA or 
CRKL siRNA (n=3). AUC was calculated from the time courses in Figure S6). * p<0.05 versus 
vehicle control, two-way ANOVA with Dunnett’s multiple comparison test. Scatter plots show 
individual data points, symbols/bars represent means and error bars indicate standard deviation of 
the mean from n experiments as stated. 
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Figure 4. Morphine, but not DAMGO, increases the proximity of MOR to desmosomal 
proteins, which control its spatiotemporal signaling profile. A-C. Stimulation of MOR-APEX2 
with morphine, but not DAMGO, for 60 min enriched an interaction network that included 
desmosomal proteins (n=3). A. Heat map showing proteins from this network that were increased 
(orange) or decreased (purple) following treatment with 1 µM morphine or 1 µM DAMGO 
compared to a vehicle control. Data are expressed as the average log2 change in protein abundance 
compared to vehicle. B. The interaction networks for the proteins that were differentially affected 
by morphine (left panel) vs DAMGO (right panel) were determined by IPA. Red indicates 
increased abundance, whereas green indicates a decrease. Data are expressed as the average log2 
change in protein abundance compared to a vehicle control. C. Proteins from B, with data 
expressed as the log2 change in protein abundance compared to vehicle control. * p<0.05, ** 
p<0.01 and *** p<0.001 versus vehicle control, two-way ANOVA with Dunnett’s multiple 
comparison test. D-J. Analysis of the activation of nuclear ERK in single HEK293 cells transiently 
expressing MOR and nucEKAR, and stimulated with vehicle, 1 µM morphine or 1 µM DAMGO. 
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D. Time course of nuclear ERK activity (n=4). E. Time course of nuclear ERK activity in cells co-
transfected with scrambled siRNA (n= 4). F. Time course of nuclear ERK activity in cells co-
transfected with DSC1 siRNA (n= 4). G. Confirmation of knockdown of DSC1 by by qRT-PCR 
(n=5). ** p<0.01 versus pcDNA control, one-way ANOVA with Dunnett’s multiple comparisons 
test. H. Time course of nuclear ERK activity in cells co-transfected with JUP siRNA (n=4). I. 
Confirmation of knockdown of JUP protein by immunoblotting. Left panel is a representative blot, 
right panel is the grouped intensity measurements from 3 independent experiments. * p<0.05 
versus pcDNA transfected control, one-way ANOVA with Dunnett’s multiple comparisons test. 
J. AUC from D, E, F and H. * p<0.05, ** p<0.01, *** p<0.001 versus vehicle control, two-way 
ANOVA with Dunnett’s multiple comparison test. Scatter plots show individual data points, 
symbols/bars represent means and error bars indicate standard deviation of the mean from n 
experiments as stated. 
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Figure 5. DAMGO and morphine differentially assemble protein-interaction networks to 
control MOR spatiotemporal signaling. A. DAMGO activation of the MOR leads to rapid 
recruitment of GRK2 and b-arrestins and facilitates a redistribution of the MOR at the plasma 
membrane (66). The DAMGO-stimulated receptor is in close proximity to IQGAP1, a large 
scaffolding protein that is required for the activation of Rac1 and nuclear ERK. IQGAP1 has been 
previously shown to bind both ERK and Rac1 (38). The DAMGO-stimulated MOR also associates 
with the adaptor protein, CRKL, which is essential for the activation of both Rac1 and nuclear 
ERK. The activation of Rac1 and nuclear ERK (10 min) occurs prior to receptor internalization 
(30-60 min (8)). B. In contrast, morphine activation of the MOR stimulates a Gai/o-Gbg-PKCa 
pathway, which increases the proximity of MOR to desmosomal proteins. Desmosomes are formed 
by two transmembrane proteins, desmocolin (DSC) and desmoglein (DSG), which in turn interact 
with the intracellular proteins plakoglobin/JUP, plakophilin (PKP) and desmoplakin (DSP) (15). 
The formation of stabilized desmosomal-like plasma membrane domains likely contributes to the 
inability of the morphine-stimulated MOR to redistribute, and therefore controls the sustained 
increase in cytosolic ERK activity. Knockdown of DSC1 (green) or JUP (cyan), facilitated a 
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transient increase in nuclear ERK in response to morphine, indicative of a redistribution of the 
receptor at the plasma membrane (8). 
 
 
 
 
 
 
 
 
 
 
 
